Unity Biotechnology Inc Reports Results For The Quarter Ended In March: Earnings Summary

Unity Biotechnology

10/05/2022 22:19

* UNITY Biotechnology Inc  UBX.OQ  reported a quarterly
adjusted
loss of 28 cents​​ per share for the quarter ended in March. The
mean expectation of five analysts for the quarter was for a loss
of 26 cents per share.
    * Reported revenue was zero​;  analysts expected zero. 
    * UNITY Biotechnology Inc's reported EPS for the quarter was
a
loss of 28 cents​.
    * The mean earnings estimate of analysts had risen by
about 16.2%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * UNITY Biotechnology Inc shares had fallen by 32.5% this
quarter and lost 48.2% so far this year.
    * The company reported a quarterly loss of $18.92 million.
    * Wall Street's median 12-month price target for UNITY
Biotechnology Inc is $6.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated May 10 at 09:18 p.m.  ​All
figures in US dollars unless otherwise stated